WASHINGTON - There is"no evidence" that a second course of Pfizer's Paxlovid will help Covid-19 patients whose symptoms return after an initial course of the antiviral, a US Food and Drug Administration official said a day after Pfizer executives advocated the idea.
In an interview on Tuesday , Pfizer Chief Executive Officer Albert Bourla said doctors could prescribe a second course of treatment toIn cases where virus levels rebound,"then you give a second course, like you do with antibiotics, and that's it," Bourla said on Tuesday. Some physicians have suggested a longer course of Paxlovid might prevent symptoms from returning.
"There is no evidence of benefit at this time" for either repeat dosing or a longer course of treatment, Farley said in the post."We are continuing to review data from clinical trials and will provide additional information as it becomes available." Meanwhile, the drugmaker studied a 10-day course of treatment in an early-stage clinical trial, and will keep the public informed on whether it plans to conduct a separate study of the treatment over that duration of time, Pfizer spokesperson Jerica Pitts said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer keeps COVID-19 sales forecast unchanged as pandemic curbs easePfizer maintained sales forecasts for its COVID-19 products on Tuesday (May 3) after a series of hikes to the sales outlook for its COVID-19 vaccine last year, in a sign that dizzying growth has slowed. Several countries across the globe have eased pandemic-linked restrictions and relaxed rules related to Being cancer-stricken and begging CPF Board to repay overdue debt; that which in any case cannot be done as the money had been commingled and funneled to private entity Temasek Holdings for Ho Ching to wager on unviable, untenable and ultimately, invariably doomed gambles
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer sees high demand for COVID-19 pill as profits jumpNEW YORK: Pfizer executives said Tuesday (May 3) they are confident of strong demand for the company\u0027s COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings. The US pharmaceutical giant, reporting surging first-quarter profits based on a big
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer sees high demand for Covid-19 pill as profits jumpNEW YORK — Pfizer executives said Tuesday (May 3) they are confident of strong demand for the company's Covid-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.
Source: TODAYonline - 🏆 1. / 99 Read more »
Pfizer sees high demand for Covid-19 pill as profits jumpPfizer executives said Tuesday they are confident of strong demand for the company's Covid-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings. This should be a crime That’s a lot of dollar for selling magic beans Fugazi
Source: YahooSG - 🏆 3. / 71 Read more »
US Secretary of State Antony Blinken tests positive for Covid-19
Source: STForeignDesk - 🏆 4. / 71 Read more »
Hong Kong to accelerate reopening from this week as Covid-19 cases fall
Source: STForeignDesk - 🏆 4. / 71 Read more »